Apostolakis S - Search Results

1

Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement.

Guo Y, Lip GY, Apostolakis S. Guo Y, et al. Among authors: apostolakis s. Pol Arch Med Wewn. 2012;122(5):235-42. Pol Arch Med Wewn. 2012. PMID: 22660688 Free article. Review.

2

The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review.

Anandasundaram B, Lane DA, Apostolakis S, Lip GY. Anandasundaram B, et al. Among authors: apostolakis s. J Thromb Haemost. 2013 May;11(5):975-87. doi: 10.1111/jth.12177. J Thromb Haemost. 2013. PMID: 23441593 Free article. Review.

3

Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review.

Udompanich S, Lip GY, Apostolakis S, Lane DA. Udompanich S, et al. Among authors: apostolakis s. QJM. 2013 Sep;106(9):795-802. doi: 10.1093/qjmed/hct129. Epub 2013 Jun 3. QJM. 2013. PMID: 23737509 Review.

4

Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.

Apostolakis S, Lane DA, Buller H, Lip GY. Apostolakis S, et al. Thromb Haemost. 2013 Nov;110(5):1074-9. doi: 10.1160/TH13-07-0552. Epub 2013 Sep 19. Thromb Haemost. 2013. PMID: 24048467 Clinical Trial.

5

Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".

Apostolakis S, Shantsila E, Lip GY, Lane DA. Apostolakis S, et al. Thromb Haemost. 2009 Nov;102(5):914-5. doi: 10.1160/TH09-08-0563. Thromb Haemost. 2009. PMID: 19888529 No abstract available.

6

The quest for new anticoagulants: from clinical development to clinical practice.

Apostolakis S, Lip GY, Lane DA, Shantsila E. Apostolakis S, et al. Cardiovasc Ther. 2011 Dec;29(6):e12-22. doi: 10.1111/j.1755-5922.2010.00160.x. Epub 2010 Jun 14. Cardiovasc Ther. 2011. PMID: 20553291 Free article. Review.

7

Atrial fibrillation (acute onset).

Lip GY, Apostolakis S. Lip GY, et al. Among authors: apostolakis s. BMJ Clin Evid. 2011 Feb 15;2011:0210. BMJ Clin Evid. 2011. PMID: 21718559 Free PMC article. Review.

8

Atrial fibrillation (chronic).

Lane DA, Apostolakis S, Boos CJ, Lip GY. Lane DA, et al. Among authors: apostolakis s. BMJ Clin Evid. 2011 Nov 10;2011:0217. BMJ Clin Evid. 2011. PMID: 22075545 Free PMC article. Review.

9

Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban.

Apostolakis S, Lip GY. Apostolakis S, et al. Expert Opin Investig Drugs. 2012 Jul;21(7):1057-64. doi: 10.1517/13543784.2012.689286. Epub 2012 May 23. Expert Opin Investig Drugs. 2012. PMID: 22616561 Review.

10

How early is early enough to prevent stroke in atrial fibrillation?

Guo Y, Lip GY, Apostolakis S. Guo Y, et al. Among authors: apostolakis s. Expert Rev Cardiovasc Ther. 2012 May;10(5):585-8. doi: 10.1586/erc.12.36. Expert Rev Cardiovasc Ther. 2012. PMID: 22651834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters